Literature DB >> 31882029

Effect of FDA Warning on Codeine and Alternate Opioid Prescribing After Pediatric Dental Procedures in Ohio.

Janice A Townsend1, Yuri V Sebastião2, Jennifer N Cooper3.   

Abstract

Purpose: Evaluate changes in codeine and alternate opioid prescription filling after pediatric dental procedures associated with the FDA's codeine black box warning for tonsillectomy/adenoidectomy.
Methods: Patients aged 0-17 years who underwent any tooth extraction or restorative procedure during August 2011-August 2016 were identified in Ohio Medicaid claims. Interrupted time series analyses were used to evaluate the impact of the FDA's warning on the rates of codeine or alternative opioid prescription fills within 14 days postprocedure.
Results: In August 2011, codeine and alternative opioid prescription fills rates after a dental procedure were 2.3 percent and 3.3 percent, respectively. These rates decreased monthly by 0.02 and 0.01 percent, respectively during the study period (P<0.0001). The FDA warning was associated with an immediate drop in codeine prescription filling of 0.4 percent (P<0.001), but there was no such association with alternative opioid prescription filling. The codeine decrease was only significant among extractions with/without concurrent restorative procedures involving males, 12- to 17-year-olds, Caucasians, and small metropolitan area residents. Conclusions: Opioid prescription filling after pediatric dental procedures decreased between 2011 and 2016 among Medicaid beneficiaries. In addition, there was a significant immediate reduction in codeine prescription filling after the FDA's codeine black box warning for tonsillectomy/adenoidectomy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31882029      PMCID: PMC6936331     

Source DB:  PubMed          Journal:  Pediatr Dent        ISSN: 0164-1263            Impact factor:   1.874


  20 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  Association of Opioid Prescriptions From Dental Clinicians for US Adolescents and Young Adults With Subsequent Opioid Use and Abuse.

Authors:  Alan R Schroeder; Melody Dehghan; Thomas B Newman; Jason P Bentley; K T Park
Journal:  JAMA Intern Med       Date:  2019-02-01       Impact factor: 21.873

3.  Codeine, ultrarapid-metabolism genotype, and postoperative death.

Authors:  Catherine Ciszkowski; Parvaz Madadi; Michael S Phillips; Albert E Lauwers; Gideon Koren
Journal:  N Engl J Med       Date:  2009-08-20       Impact factor: 91.245

4.  The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio.

Authors:  Scott G Weiner; Olesya Baker; Sabrina J Poon; Ann F Rodgers; Chad Garner; Lewis S Nelson; Jeremiah D Schuur
Journal:  Ann Emerg Med       Date:  2017-05-23       Impact factor: 5.721

5.  Effect of FDA Investigation on Opioid Prescribing to Children After Tonsillectomy/Adenoidectomy.

Authors:  Kao-Ping Chua; Mark G Shrime; Rena M Conti
Journal:  Pediatrics       Date:  2017-11-16       Impact factor: 7.124

Review 6.  Use of interrupted time series analysis in evaluating health care quality improvements.

Authors:  Robert B Penfold; Fang Zhang
Journal:  Acad Pediatr       Date:  2013 Nov-Dec       Impact factor: 3.107

7.  Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.

Authors:  Greta A Bushnell; Til Stürmer; Sonja A Swanson; Alice White; Deborah Azrael; Virginia Pate; Matthew Miller
Journal:  Psychiatr Serv       Date:  2015-11-16       Impact factor: 3.084

Review 8.  Is there a role for therapeutic drug monitoring with codeine?

Authors:  Lauren E Kelly; Parvaz Madadi
Journal:  Ther Drug Monit       Date:  2012-06       Impact factor: 3.681

9.  Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.

Authors:  I Johansson; E Lundqvist; L Bertilsson; M L Dahl; F Sjöqvist; M Ingelman-Sundberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

Review 10.  A scoping review exploring the opioid prescribing practices of US dental professionals.

Authors:  May Nawal Lutfiyya; Andrew J Gross; Nena Schvaneveldt; Alexandra Woo; Martin S Lipsky
Journal:  J Am Dent Assoc       Date:  2018-09-08       Impact factor: 3.634

View more
  1 in total

Review 1.  Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.

Authors:  Sonya C Tang Girdwood; Katelyn M Rossow; Sara L Van Driest; Laura B Ramsey
Journal:  Pediatr Res       Date:  2021-04-06       Impact factor: 3.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.